Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | FZD5 |
Upstream (Parents) |
---|
(<<) CEACAM1 → FZD5 |
(<<) DUSP2 → FZD5 |
(<<) DVL1 → FZD5 |
(<<) EBP → FZD5 |
(<<) EGFR → FZD5 |
(<<) FUT4 → FZD5 |
(<<) GLTPD1 → FZD5 |
(<<) HDAC8 → FZD5 |
(<<) ILKAP → FZD5 |
(<<) ISLR → FZD5 |
(<<) ITGB1 → FZD5 |
(<<) JUN → FZD5 |
(<<) LAMB2 → FZD5 |
(<<) LOC92249 → FZD5 |
(<<) MT1P2 → FZD5 |
(<<) PLCD3 → FZD5 |
(<<) SOCS1 → FZD5 |
(<<) TFPI2 → FZD5 |
Downstream (Children) |
---|
FZD5 → ARHGAP10 (>>) |
FZD5 → DNM2 (>>) |
FZD5 → EPHB2 (>>) |
FZD5 → FAS (>>) |
FZD5 → HMGA2 (>>) |
FZD5 → INVS (>>) |
FZD5 → ITGA6 (>>) |
FZD5 → SEMA3A (>>) |
FZD5 → TNFRSF11A (>>) |